The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health
Open accessAbstract
cal research (2-5), so the need for disease markers that represent islet-damaging or islet-protective events, such as numbers and phenotype of circulating islet autoreactive T cells, has become more urgent.In terms of distinguishing pathological from protective responses, it has been proposed that proinflammatory (type 1) T cell immunity is responsible for islet damage, while humoral (type 2) immunity may be protective, or at least benign (6).These speculations are largely based on studies in animal models, however, and even then the findings have not always been consistent with the hypothesis (7, 8).In addition, it is proposed that naturally arising, regulatory T cell populations are available to curb autoimmune potential (9), but as yet there is no evidence for islet antigen-specific regulatory cell populations existing in humans.Obtaining answers to these key questions has been hampered by technical difficulties, since the constraints on assay design for the detection of islet autoreactive T cells are considerable.Studies can only make use of peripheral blood, in which islet autoreactive T cells are likely to be rare, so assays must be highly sensitive.Ideally, in the context of therapeutic intervention trials using immune modulators, the readout for islet autoreactive T cells should represent a phenotype relevant to ongoing islet inflammation or the restoration of tolerance.Finally, to achieve accurate enumeration of responder cells, assays should avoid in vitro expansion steps.The cytokine enzyme-linked immunosorbent spot (ELISPOT) assay has many of the requisite qualities (10).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
Atkinson, M. A., & Eisenbarth, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05415-0 · Cited by 1,491
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Primer on Certain Elements of Medical Decision Making
McNeil, B. J., Keeler, E., & Adelstein, S. J. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507312930501 · Cited by 1,140
Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
Liblau, R. S., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,105
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Panina‐Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G., & Lanzavecchia, A. (1989) · European Journal of Immunology · doi:10.1002/eji.1830191209 · Cited by 713
The use of relative operating characteristic (ROC) curves in test performance evaluation.
Beck, & Shultz, E. K. (1986) · PubMed · Cited by 621
The enemy within: keeping self-reactive T cells at bay in the periphery
Walker, L. S. K., & Abbas, A. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri701 · Cited by 596
T Helper Cell Subsets in Insulin-Dependent Diabetes
Katz, J. D., Benoist, C., & Mathis, D. (1995) · Science · doi:10.1126/science.7761837 · Cited by 593
Raz, I., Elias, D., Avron, A., Tamir, M., Metzger, M., & Cohen, I. R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06801-5 · Cited by 508
Diabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Susceptibility to type I diabetes: HLA-DQ and DR revisited
she, J.-X. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10014-1 · Cited by 320
Day, C. L., Seth, N. P., Lucas, M., Appel, H., Gauthier, L., Lauer, G. M., Robbins, G. K., Szczepiorkowski, Z. M., Casson, D. R., Chung, R. T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18509 · Cited by 294
Suppressor T cells – they’re back and critical for regulation of autoimmunity!
Chatenoud, L., Salomon, B., & Bluestone, J. A. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820112.x · Cited by 273
Serreze, D. V., Chapman, H. D., Post, C. M., Johnson, E. A., Suarez-Pinzon, W. L., & Rabinovitch, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1352 · Cited by 170
T-Cell Responses to Autoantigens in IDDM: The Search for the Holy Grail
Roep, B. O. (1996) · Diabetes · doi:10.2337/diab.45.9.1147 · Cited by 166
Self-citationRegulatory Role of T Cells Producing both Interferon γ and Interleukin 10 in Persistent Infection
Trinchieri, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.f53 · Cited by 164
Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4
Peakman, M., Stevens, E. J., Lohmann, T., Narendran, P., Dromey, J. A., Alexander, A., Tomlinson, A. J., Trucco, M., Gorga, J. C., & Chicz, R. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7936 · Cited by 160
Self-citationRoep, B. O., Atkinson, M. A., Endert, P. V., Gottlieb, P. A., Wilson, S. B., & Sachs, J. A. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0312 · Cited by 127
Self-citationCongia, M., Patel, S. D., Cope, A. P., Virgiliis, S. D., & Sønderstrup, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3833 · Cited by 107
Danke, N. A., & Kwok, W. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3163 · Cited by 101
Bingley, P. J., Williams, A. J. K., & Gale, E. A. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.11.1796 · Cited by 93
Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells
Schloot, N. C., Meierhoff, G., Faresjö, M. K., Ott, P. A., Putnam, A. L., Lehmann, P., Gottlieb, P. A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00111-2 · Cited by 81
Self-citationPeakman, M., Tree, T. I. M., Endl, J., Endert, P. V., Atkinson, M. A., & Roep, B. O. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1749 · Cited by 81
Self-citationAlmawi, W. Y., Tamim, H., & Azar, S. T. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5699 · Cited by 79
Cutting Edge: Anti-Inflammatory Properties of Low Levels of IFN-γ
Flaishon, L., Topilski, I., Shoseyov, D., Hershkoviz, R., Fireman, E. M., Levo, Y., Marmor, S., & Shachar, I. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3707 · Cited by 75
Schatz, D., & Bingley, P. J. (2001) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2001.14.s1.619 · Cited by 59
Durinovic‐Belló, I., Boehm, B. O., & Ziegler, A. (2002) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0566 · Cited by 47
Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes
Narendran, P., Williams, A. J. K., Elsegood, K. A., Leech, N., & Dayan, C. M. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.332 · Cited by 32
Self-citationMarčiulionytė, D., Williams, A. J. K., Bingley, P. J., Urbonaitė, B., & Gale, E. A. M. (2001) · Diabetologia · doi:10.1007/s001250051574 · Cited by 27 · cited 2×
“Totals 6/25 3/25 8/25 3/25 7/25 4/25 2/17 8/17 3/17 (%) (24) (12) (32) (12) (28) (16) (12) (47) (18)”
BackgroundAstill, T. P., Ellis, R. J., Arif, S., Tree, T. I. M., & Peakman, M. (2003) · Diabetologia · doi:10.1007/s00125-003-1070-3 · Cited by 23
Self-citationT-Cell markers in Type I diabetes: progress, prospects and realistic expectations
Available, N. A. N. (2000) · Diabetologia · doi:10.1007/s001250070001 · Cited by 12
Cited by
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
Self-citationTarbell, K. V., Yamazaki, S., Olson, K., Toy, P., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040180 · Cited by 738
Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease
Fujinami, R. S., von Herrath, M. G., Christen, U., & Whitton, J. L. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.80-94.2006 · Cited by 679
Metadata
- Authors
- Arif, S., Tree, T. I., Astill, T. P., Tremble, J. M., Bishop, A. J., Dayan, C. M., Roep, B. O., & Peakman, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-02-01
- Volume
- 113
- Issue
- 3
- Pages
- 451-463
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2048114019
- Cited by
- 479
- References
- 34
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.